首页
メSomnus丶せ
影响力0.00
经验值0.00
粉丝7
设备工程师
LNG储罐设计压力与温度的确定依据什么? 目前有一个LNG埋地储罐的设计,设计压力待确定。请有经验的学长给予赐教,多谢! 查看更多 0个回答 . 4人已关注
高温固体颗粒流速(流量)的测量? 请问各位高手:高温固体颗粒流速怎样测量,用什么仪器经济耐用,谢谢!查看更多 0个回答 . 5人已关注
使用无极灯经验? 本人在新上氯碱项目任电气主管, 防爆灯 光源拟使用无极灯,各位前辈认为如何?查看更多 1个回答 . 1人已关注
换热器超温问题? 我厂的几台 换热器 ,设计时的数据为:设计温度200,设计压力3.92MPa,工作压力1.4MPa,工作温度为335。 运行时的数据为:工作压力1.1MPa,工作温度330,不知是否符合要求.查看更多 7个回答 . 1人已关注
苯产品中甲苯含量高原因? 你好,现在遇到一个难题请帮忙指点!我装置是 环丁砜 液液抽提,产品只抽苯!现在苯产品中 甲苯 含量在0.4%左右居高不下,而且 汽提塔 顶灌液位一直上升,其中反洗液中非芳占20%芳烃占80%溶剂占0.2%,汽提塔底温由原来165度降到150度,液位还在上涨!现在进料5.5吨每小时,溶剂比3.5左右,反洗比0.7左右,原料中苯含量在30%左右,甲苯占0.04%原料组分C6~C7!汽提塔顶温105,底温150,顶压0.12MPA,应怎样调整请指点!!!查看更多 1个回答 . 2人已关注
一股天然气从100度降温到45度,怎么计算换热量? 天然气为 混合物 ,管子为DN32,流量150Nm3/h查看更多 3个回答 . 3人已关注
国际知名品牌Target Mol与Topscience开展战略合作? 2014 年 12 月, Topscience 与 TargetMol 正式签署为期三年的战略合作协议,作为 Target Mol 在大中国地区的服务机构,陶素将负责 TargetMol 在中国市场的产品销售、技术应用与支持等各项业务,为中国大陆及包括台湾,香港和澳门在内的大中国地区客户提供快速,便捷的服务 Topscience 将始终秉承“ Chemistry for a better life ” 之理念,一如既往地为中国化学行业广大科研和生产用户提供品质卓越的产品与一流的服务! TargetMol 位于美国生物医药最发达的马赛诸塞州,这里有多达 900 家 Healthcare 领域的公司,从大型医院到生物技术公司,都对药物小分子的研究注以浓厚的兴趣。为了以最快的速度获得新型药物分子或进行细胞诱导的实验,研究者利用已经上市或报道的药物小分子进行老药新用或信号通路的研究。但通常这些药物小分子的收集工作是非常繁琐的,会耗费科学家们大量的时间。同时,由于分子和细胞水平的实验用量较小,又增加了对实验材料的浪费。为了解决这个问题, TargetMol 公司推出了各种上市药物小分子库和活性 抑制剂 小分子库,以 1mg , 5mg 的干粉和 10mM 的溶液向医药领域的客户提供灵活的产品集合,帮助生物学家和药学家得到了具有明确活性和毒性的上市药物研究的小分子,并收集了大量的抑制剂小分子以供科学家们进行细胞信号转导,细胞诱导,老药新用以及阳性对照的实验。 在未来的三年中,TargetMol将授权Topscience经营其中国市场业务,依靠Topscience强大的市场优势和TargetMol自身产品的竞争力,为中国的生物,药学和化学家们提供更加便捷和优质的活性小分子化合物。 Target Mol 的优势产品系列摘录如下: 1. USA Drug Collection USA Drug Collection has already been put into the market, including1280 kinds of small molecular drug compounds in the America. These medicinesare assigned by USP or USAN. There are different format for these drugcompounds 1mg, 5mg and DMSO 10mM dissolvent concentration. All the compounds inthis library not only make bioassay experiments, but also finish clinicaleffective assessment. Every compound includes product data information indetail. Such as structure, CAS number, molecular formula, molecular weight,bioactivity and commodity name. Pharmacology and toxicology referencedocumentation is also included. Advantages There are rich document references and reliable data demonstrations.Every compound is selected by medicinal and biological chemist, has goodbiological activity and structural diversity. These medicines corresponding disease and medicine toxicologicaldocument has been open in public. You can be fully supported by toxicologicaldata and find new functions. The average purity is above 95%. If there are no specialinstructions, purity of every compound are all higher than 90%. Applications It is adopted by new users for old drugs, module establishment, drugselection experiments and so on. On the one hand, we offer convenient researchtools for known medicinal activity assessment. On the other hand, we offerexcellent research tools to cell biologist to conduct cell induce experiment. Package condition Dry chemical powder quality guarantee period is more than 1 year. We suggest liquor products are used up in 6 months. Because withrepeated frosted, it is possible to appear products’ degradation. The delivery cost is different depending on the customers’ countries. The list price for the USA Drug Collection is as follows. 250ul 10mM concentration in DMSO solution of USA Drug Collection:12800 USD 500ul 10mM concentration in DMSO solution of USA Drug Collection:18602 USD 1ml 10mM concentration inDMSO solution of USA Drug Collection: 23688 USD 1mg USA Drug Collection:12800USD 5mg 1280 USA Drug Collection: 37120 USD 2.Selective Drug Collection The selective Drug Collection including 400 kinds of small moleculardrug on the America, Europe and Asia market. These medicines are certified byUSP, USAN, INN, BAN, JAN and so on. All are in stock, twelve 96 plate, is DMSO10mM dissolvent concentration. Different from other products on the market, the400 products not only make bioassay experiments, but also finish clinicaleffective assessment. Every compound includes product data information indetail. Such as structure, CAS number, molecular formula, molecular weight,bioactivity and commodity name. Pharmacology and toxicology referencedocumentation is also included. Advangtages There are rich document references and reliable data demonstrations.Every compound is selected by medicinal and biological chemist, has goodbiological activity and structural diversity. These medicines corresponding disease and medicine toxicologicaldocument has been open in public. You can be fully supported by toxicologicaldata and find new functions. The average purity is above 95%. If there are no specialinstructions, purity of every compound are all higher than 90%. Application It is adopted by new users for old drugs, module establishment, drugselection experiments and so on. On the one hand, we offer convenient researchtools for known medicinal activity assessment. On the other hand, we offerexcellent research tools to cell biologist to conduct cell induce experiment. Package condition We can offer 1mg to 5mg packing dry powder, and also can provide10mmol/L DMSO solution. Dry chemical powder quality guarantee period is morethan 1 year. We suggest liquor products are used up in 6 months. Because withrepeated frosted, it is possible to appear products’ degradation. 250ul 10mM concentration in DMSO solution: 4,000 USD 500ul 10mM concentration in DMSO solution: 5,950 USD 1ml 10mM concentration inDMSO solution: 7,900 USD 1mg Drug Collection: 4,000USD 5mg Drug Collection:11,500USD 3 . HTS Drug Collection HTS Drug Collection has already emerged into the market, including2000 kinds of small molecular drug on in the North AmericanAmerica, Europeanand Asian market. These medicines are certified by USP,USAN, INN, BAN, JAN andso on. All are in stock, twelve 96 plate, is withDMSO 10mMdissolventconcentration in DMSO. Different from other products on in themarket, the 2000 products have been certified not only make by bioassayexperiments, but also finish through clinical effective assessment. Everycompound includes product data information in detail. Such, such as structure,CAS number, molecular formula, molecular weight, bioactivity and commodityname. Pharmacology and toxicology reference documentation is also included. Advantages There are rich abundent abundant document references and reliabledata demonstrations. Selected by medicinal and biological chemist, eEverycompound is selected by medicinal and biological chemist, has good biologicalactivity and structural diversity. Disease targeted by tThese medicines corresponding disease andmedicine toxicological document has have been open in public. You can be fullysupported by toxicological data and find new functions. The average purity is above 95%. If there are no special instructionsnotice,purity of every compound are all higher than 90%. Applications It is adopted by in new users research/disease for old drugs, moduleestablishment, drug selection experiments and so on. On the one hand, we offerconvenient research tools for known medicinal activity assessment. On the otherhand, we offer excellent research tools to for cell biologist to conduct cellinduce experiment. There are two examples, one is MItifus, which is was used for curingmammary cancer and , now it treats leishmanisis (leishmaniasis is zoonosiscaused by leishmansia) It is transmitted by articulate and arthropods. Thisdisease is happened in more than 100 countries. Every year the number of newcases is more than 40 million, causing 5 million people death. Another theother one is Viagra. This disease is used for curing new colic, while clinicaleffect is less than expected, but in America in Pfizer Company’s at AusterBuilding accidently found that indViagra made some patients with heart diseasetake Viagra because of heart disease,causing Penis smooth musclerelaxationbecauserelaxation because of side effect. Because ofWith blowingblood increasing, it improves improved erectile function. Then through repeatedexperiment, it is was certified that Viagra iswas definitely effective for erectile function. Package condition We can offer not only 1mg to 5mg packing dry powder, and but alsocan provide 10mmol/L DMSO solution. The war renty for dDry chemical powderquality guarantee period is more than 1 year. We suggest that liquor productsare should be used up in within 6 months. Because withWith repeated frosted, itis possible to appear products’ degradation. The list price for the HTS Drug Collection is as follows. 250ul 10mM concentration in DMSO solution of USA DrugCollection: 199,700 USD 500ul 10mM concentration in DMSO solution of USA DrugCollection: 299,500 USD 1ml 10mM concentration inDMSO solution of USA Drug Collection: 399,300 USD 1mg USA Drug Collection: 199,700 USD 5mg 1280 USA Drug Collection: 599,950 USD 4. Europe&Asia Durg Collection Our drug compounds Collection including 480 kinds of small moleculardrug marketed in Europe and/or Asia. These medicines are certified by INN / BAN/ JAN and so on. Different from other products on the market, the 480 productsnot only make bioassay experiments, but also finish clinical effectiveassessment. Every compound includes product data information in detail. Such asstructure, CAS number, molecular formula, molecular weight, bioactivity andcommodity name. Pharmacology and toxicology reference documentation is alsoincluded. Advantages There are abundantdocument references and reliable datademonstrations. Every compound selected by medicinal and biological chemisthasgood biological activity and structuraldiversity. These medicines corresponding disease and medicine toxicologicaldocument has been open in public. You can be fully supported by toxicologicaldata and find new functions. The average purity is above 95%. If there are no special instructions,purity of every compound are all higher than 90%. Applications It is adopted by new users for old drugs, module establishment, drugselection experiments and so on. On the one hand, we offer convenient researchtools for known medicinal activity assessment. On the other hand, we offerexcellent research tools to for cell biologist to conduct cell induceexperiment. Package condition We can offer not only 1mg to 5mg packing dry powder, and butalso canprovide 10mmol/L DMSO solution. Dry chemical powder qualityThe guaranteewarrantyperiod for dry chemical powderis more than 1 year. We suggest liquorproducts are used up in 6 months. Because withWith repeated frosted, it ispossible to appear products’ degradation. The list price for the Europe &Asia Drug Collection is asfollows. 250ul 10mM concentration in DMSO solution: 4,800 USD 500ul 10mM concentration in DMSO solution: 7,200 USD 1ml 10mM concentration inDMSO solution: 9,500 USD 1mg USA Drug Collection:4,800 USD 5mg 1280 USA Drug Collection: 13,900 USD 5. Natural Compounds Library Natural compounds are famous for the novelty of the structures.There are 800 natural products in our Natural compoundslibrary.These naturalproduct screening compounds was refinedfrom plants and microorganisms. Mostcompounds have purity above 90% on average. The structures and stereochemistryare confirmed by various physicochemical analytical methods, including NMR,mass spectroscopy and in some cases X-ray analysis. They are supplied in96-well format, with other formats available upon request.We welcomecherry-picking of individual natural products from our Natural compoundslibrary. The list price for the Collection is as follows. 250ul 10mM concentration in DMSO solution: 11,500 USD 500ul 10mM concentration in DMSO solution: 17,500 USD 1ml 10mM concentration inDMSO solution: 22,000 USD 1mg Collection: 11,500 USD 5mgCollection: 33,350 USD 6. Human Endogenous Compounds This library includes formed molecules or intermediatemolecules inthe process of the human body existed metabolic process. For example, relatedwith the human peripheral nervous system has Ach,NA, histamine and so on. Theresearch based Endogenous biological active substance is a new hot center indrug development. We can provide more than 200 human endogenous compounds,including Human endogenous compoundsEC_ , organism, Pathways, Formula, Donor,Acceptor, LogP, MW related data. 1mg to 5mg can both be provided. There are several endogenous active substances in anti-aging effectlisted below: 1. Hyaluronic acid Anti-Aging principle is transparent human natural moisturizingingredients, keep moist and promoteother activity ingredient absorb, offer good environment for the dermalcollagen and elastic fiber synthesis and relieve aging wrinkles. 2. SOD SOD is abbreviation of Super Oxide Dimutesef. Its Chinese name isSuper Oxide Dimutesef. It is a biological antioxidant enzyme in organisms. Itwidely located in different kinds of organism such as animals, plants andmicroform and so on.SOD has special bioactivity. It is primary substances ineliminating free radical. Level in organism means direct index of the aging anddeath. Now it can be proved that oxygen free radicals are more than 60.It canblock oxygen free radicals harmful to cell, repair damaged cell in time,andthecomplex causes of free radicals causes harmful to cells. Because of modernpressure, environment pollution all kinds of radiation and excessive movementwill cause a large amount of oxygen free radical. Therefore,SOD plays animportant role in Biological antioxidant mechanism. The list price for the USA Drug Collection is as follows. 250ul 10mM concentration in DMSO solution: 9,700 USD 500ul 10mM concentration in DMSO solution: 14,550 USD 1ml 10mM concentration inDMSO solution: 18,788 USD 1mg Collection: 9,700USD 5mgCollection: 27,120 USD 7. Metabolism & Impurity Library Metabolism and impurity library is selected from 1 million activeproduct libraries, 200 products in all, high cost performance, good diversity;ability of repeated supply is strong. Purity of most compoundsis higher than95%,suitable for related customers demand for drug screening research. Allproducts are packed in two dimension code Matrix-379096 plates. Standardpackage is 1mg dry powder ofeach product, which is convenient for storage andusage. If you need solution or other specifications, we can also provide. Why we recommend you thislibrary? With development of research, Scientists has discovered manydefinite bioactivities in Drug / metabolite isomers. Forexample,Dextropropoxyphene2 dextroisomerkill the pain,levoisomerrelief one’s cough. D sotalolbelongs tobeta blocker. Because these compounds have rich pharmacology elevation data inresearch, it can help scientists save a large number of pharmacokinetics experiments.Elevate its other potential activity directly. Put these experimental tools fornew uses of old drugs to research and innovate. The list price for the Metabolism and impurity library Collection isas follows. 250ul 10mM concentration in DMSO solution: 5,900 USD 500ul 10mM concentration in DMSO solution: 8,673 USD 1ml 10mM concentration inDMSO solution: 11,500 USD 1mg Drug Collection: 5,900USD 5mg Drug Collection: 17,110 USD 查看更多 0个回答 . 1人已关注
IFV兼做冷能发电的装置? 有没有供货商可以交流啊? 查看更多 0个回答 . 4人已关注
大家推荐下考试带什么字典好啊? 带本小巧而实用的双语字典,可查英语也可查汉语.大部头的字典太厚反而不好查找单词.查看更多 51个回答 . 2人已关注
Heater进出口流量? WARNING BLOCK B21 IS NOT IN MASS BALANCE: MASS INLET FLOW = 0.16808316E+02, MASS OUTLET FLOW = 0.15427102E+02 RELATIVE DIFFERENCE = 0.89531640E-01 IMBALANCE IS DUE TO A LOOSE TEAR TOLERANCE STREAM 40 TOLERANCE = 0.10000000 , 老是不平衡,需要从那些方面调整? 查看更多 2个回答 . 2人已关注
在燃烧炉中主要发生什么反应?放出热量? 在燃烧炉中主要发生什么反应?放出热量查看更多 3个回答 . 1人已关注
红色硫酸渣变黑色硫酸渣技术? 本公司现有一20万吨/年 硫酸 厂,求能使 硫酸渣 由红色变为黑色的技术,有了解的请留下联系方式,我公司可以通过技术转让的方式合作,或者大家可以大概说一下原理,以便交流~!查看更多 8个回答 . 3人已关注
ACE2006字体设置的问题? 在学习ace2006中文版,设置了字体使用gbcbig.shx字体,但在元件的特性描述desc1中输入中文后在cad图纸还是显示乱码,请教各位怎么处理?查看更多 0个回答 . 2人已关注
ASPEN V7打开文件重新运行后出现此错误? ASPEN V7打开文件重新运行后出现此错误,为此重装了很多次,但是每次运行都会出现这样的错误。重新建立一个新的模拟就不会发生这种错误,是在不知道哦啊错在什么地方,谁知道的话能给指点一下,谢谢 << Run reinitialized 11:43:09 Sun Sep 27, 2009>> ->Processing input specifications ... * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIFAC METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 3350 1 1070 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIFAC METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 2 CL 3 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 3350 2 1015 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-LBY METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 3 CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1070 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-LBY METHOD CANNOT BE COMPLETED FOR COMPONENT B0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1015 6 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-LBY METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 2 CL 3 CL 5 CL 6 SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1015 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-DMD METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 3 CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1070 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-DMD METHOD CANNOT BE COMPLETED FOR COMPONENT B0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1015 6 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-DMD METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 2 CL 3 CL 5 CL 6 SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1015 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-R4 METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 3350 1 1070 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE UNIF-R4 METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 2 CL 3 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 3350 2 1015 2 STRUCTURE FOR COMPONENT HSICL3 HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. STRUCTURE FOR COMPONENT SICL4 HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE BENSON METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: C 2 SI 3 CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 104 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE JOBACK METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 3 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 116 3 104 1 105 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE BENSONR8 METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: C 2 SI 3 CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 104 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE GANI METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 3 CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1070 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE PARACHOR METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 3 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 111 3 105 1 104 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE REICHENB METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 3 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 104 1 105 1 115 3 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE RUZICKA METHOD CANNOT BE COMPLETED FOR COMPONENT A0. THE FOLLOWING ATOMS WERE NOT MATCHED: C 2 SI 3 CL 4 CL 5 CL 6 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 104 1 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE PARACHOR METHOD CANNOT BE COMPLETED FOR COMPONENT B0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 100 6 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE REICHENB METHOD CANNOT BE COMPLETED FOR COMPONENT B0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 100 6 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE RUZICKA METHOD CANNOT BE COMPLETED FOR COMPONENT B0. THE FOLLOWING ATOMS WERE NOT MATCHED: C 1 C 2 C 3 C 4 C 5 C 6 SI 7 SI 8 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE BENSON METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 2 CL 3 CL 5 CL 6 SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 418 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE JOBACK METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 116 4 100 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE BENSONR8 METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: C 1 CL 2 CL 3 C 4 CL 5 CL 6 SI 7 SI 8 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE GANI METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: CL 2 CL 3 CL 5 CL 6 SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 1015 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE PARACHOR METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 111 4 100 2 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE REICHENB METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: SI 7 SI 8 THE FUNCTIONAL GROUPS GENERATED GROUP NUMBER NO. OF OCCUR. GROUP NUMBER NO. OF OCCUR. 100 2 115 4 * WARNING IN PHYSICAL PROPERTY SYSTEM FUNCTIONAL GROUP GENERATION FOR THE RUZICKA METHOD CANNOT BE COMPLETED FOR COMPONENT C0. THE FOLLOWING ATOMS WERE NOT MATCHED: C 1 CL 2 CL 3 C 4 CL 5 CL 6 SI 7 SI 8 STRUCTURE FOR COMPONENT DCS HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. STRUCTURE FOR COMPONENT FECL3 HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. STRUCTURE FOR COMPONENT HCL HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. STRUCTURE FOR COMPONENT BCL3 HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. STRUCTURE FOR COMPONENT PCL3 HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. STRUCTURE FOR COMPONENT MDCS HAS NOT BEEN DEFINED. PCES CANNOT USE GROUP-CONTRIBUTION METHODS TO ESTIMATE MISSING PROPERTIES USE THE STRUCTURES PARAGRAPH TO DEFINE STRUCTURES OF THIS COMPONENT. * WARNING IN PHYSICAL PROPERTY SYSTEM PARAMETER CPIG (DATA SET 1) FOR COMPONENT B0: UNREASONABLE HEAT CAPACITY CALCULATED AT TEMPERATURE LOWER BOUND, VALUE = 0.0000 J/KMOL-K. VALUE SHOULD BE GREATER THAN MINIMUM ALLOWABLE VALUE = 8314.3 J/KMOL-K. PLEASE CHECK YOUR INPUT FOR THE CPIG PARAMETERS. ** ERROR IN THE "PROP-SET" PARAGRAPH WHICH BEGINS ON LINE 291 PROPSET NAME: HXDESIGN THE PROPERTY "HMX" CANNOT BE CALCULATED FOR A MASS BALANCE ONLY SIMULATION. THIS PROPERTY SET WILL BE IGNORED. ** ERROR IN THE "PROP-SET" PARAGRAPH WHICH BEGINS ON LINE 291 PROPSET NAME: HXDESIGN THE PROPERTY "CPMX" CANNOT BE CALCULATED FOR A MASS BALANCE ONLY SIMULATION. THIS PROPERTY SET WILL BE IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 342 BLOCK NAME: 1TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 342 BLOCK NAME: 1TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 355 BLOCK NAME: 2T0WER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 355 BLOCK NAME: 2T0WER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 368 BLOCK NAME: 3TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 368 BLOCK NAME: 3TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 381 BLOCK NAME: 4TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 381 BLOCK NAME: 4TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 394 BLOCK NAME: 5TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 394 BLOCK NAME: 5TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 407 BLOCK NAME: 6TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 407 BLOCK NAME: 6TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 420 BLOCK NAME: 7TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 420 BLOCK NAME: 7TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 433 BLOCK NAME: 8TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 433 BLOCK NAME: 8TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 446 BLOCK NAME: 9TOWER MODEL NAME: RADFRAC SKW: COND-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "BLOCK" PARAGRAPH WHICH BEGINS ON LINE 446 BLOCK NAME: 9TOWER MODEL NAME: RADFRAC SKW: REB-HCURVE TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. *** SEVERE ERROR IN THE "STREAM-REPOR" PARAGRAPH WHICH BEGINS ON LINE 480 SKW: STANDARD TKW: PROPERTIES "HXDESIGN" HAS NOT BEEN DEFINED AS A VALID PROPERTY LIST ID. PROBABLE SPELLING ERROR. PARAGRAPH IGNORED. ! Errors while processing input specifications查看更多 8个回答 . 2人已关注
求教:炼铁高炉上的液压站做什么用的 工作原理是什么? 菜鸟初到炼铁厂 什么都不懂 以上问题 请好心人解答 谢谢 查看更多 2个回答 . 5人已关注
酸性水罐顶气都是如何脱臭处理的? 如题:酸性水罐顶气都是如何脱臭处理的? 大家都是选择什么样的工艺处理方法? 如何有效去除酸性水罐顶气相中烃类的?查看更多 10个回答 . 4人已关注
苯氧基磷腈阻燃剂的生产与应用方向? 苯氧基磷腈是现在市场上新兴的 阻燃剂 ,但因优异的使用性能,这正在被越来越多的客户所接受。 其上游的 中间体 六氯 也成为了某新型材料生产研发的不可或缺的材料之一。作为厂家,如何让用户采购到质优价廉的产品,厂家与用户怎样的交流更为合适?在应用上用户又能提出怎样指导性的建议?有相关生产或应用经验的老师可以交流一下 查看更多 1个回答 . 5人已关注
换热管稳定许用应力问题? 换热管材料GB151上就有,楼主想要学习 换热器 ,先把GB151熟悉一下,下面是换热管的材料、标准、规格及公差,都是GB151上的 [ ]查看更多 3个回答 . 2人已关注
有关邻氨基苯甲酸的生产? 这个东西可不是随便制的,一类易制毒化学品!查看更多 1个回答 . 5人已关注
塑料行业必须知道的专业常识? 1.玻璃化转变温度 高聚物由高弹态转变为玻璃态的温度,指无定型 聚合物 (包括结晶型聚合物中的非结晶部分)由玻璃态向高弹态或者由后者向前者的转变温度,是无定型聚合物大分子链段自由运动的最低温度,通常用Tg表示,随测定的方法和条件有一定的不同。高聚物的一种重要的工艺指标。在此温度以上,高聚物表现出弹性;在此温度以下,高聚物表现出脆性,在用作塑料、橡胶、合成纤维等时必须加以考虑。如 聚氯乙烯 的玻璃化温度是80℃。但是,它不是制品工作温度的上限。比如,橡胶的工作温度必须在玻璃化温度以上,否则就失去高弹性。 博洋小马虽然是做PVC 加工助剂 的,但是这些专业也是必须要懂滴,为啥腻,因为只有懂的更多更专业才能更好的为顾客服务,这些概念绝对准确,因为这是我们技术深思熟虑写下来滴 2.维卡软化温度 维卡软化温度是将热塑性塑料放于液体传热介质中,在一定的负荷和一定的等速升温条件下,试样被1平方毫米的压针头压入1毫米时的温度,对应的国标是GB/T 1633-2000。维卡软化温度是评价材料耐热性能,反映制品在受热条件下物理力学性能的指标之一。材料的维卡软化温度虽不能直接用于评价材料的实际使用温度,但可以用来指导材料的质量控制。维卡软化温度越高,表明材料受热时的尺寸稳定性越好,热变形越小,即耐热变形能力越好。 3.韧性 韧性表示材料在塑性变形和断裂过程中吸收能量的能力。韧性越好,则发生脆性断裂的可能性越小。韧性可在材料科学及冶金学上,韧性是指当承受应力时对折断的抵抗,其定义为材料在破裂前所能吸收的能量与体积的比值。 4.拉伸强度 博洋小马虽然做PVC加工助剂,但是我们有技术团队,如果您制品有什么问题都可以过来咨询,不是非要买产品我们才欢迎,只要您联系我们,我们都欢迎 抗拉强度即表征材料最大均匀塑性变形的抗力,拉伸试样在承受最大拉应力之前,变形是均匀一致的,但超出之后,金属开始出现缩颈现象,即产生集中变形;对于没有(或很小)均匀塑性变形的脆性材料,它反映了材料的断裂抗力。符号为Rm(GB/T 228-1987旧国标规定抗拉强度符号为σb),单位为MPa。 5.弯曲强度 弯曲强度是指材料在弯曲负荷作用下破裂或达到规定弯矩时能承受的最大应力,此应力为弯曲时的最大正应力,以MPa(兆帕)为单位。它反映了材料抗弯曲的能力,用来衡量材料的弯曲性能。 6.断裂伸长率 指试样在拉断时的位移值与原长的比值,以百分比表示(%)。 断裂伸长率 的计算方法: 原长L;横截面积A,在轴向拉力N作用下,变形后的断裂长度为L',于是断裂伸长△L=L'-L 应变为ε=△L/L 断裂伸长率=ε*100% 7.低温脆化温度 塑料低温力学行为的一种量度。以具有一定能量的冲锤冲击试样时,当试样开裂几率达到50%时的温度称脆化温度。查看更多 0个回答 . 4人已关注
简介
职业:张家港康得新光电材料有限公司 - 设备工程师
学校:茂名职业技术学院 - 机电化工系
地区:海南省
个人简介:因为有伤口,才能感受到自己的存在查看更多
已连续签到天,累积获取个能量值
  • 第1天
  • 第2天
  • 第3天
  • 第4天
  • 第5天
  • 第6天
  • 第7天
 
这是一条消息提示
 
提醒
您好,您当前被封禁天,这天内您将不能登陆盖德问答,离解封时间还有
我已了解
提醒
提问需要5个能量值,您当前能量值为,请完成任务提升能量值
去查看任务